Results 131 to 140 of about 459,720 (267)
Genetic Approach for Joint Transmission Grouping in Next-Generation Cellular Networks. [PDF]
Sensors (Basel), 2022 Kuo YP, Yu YJ, Hong TP, Lai WK.
europepmc +1 more source
Molecular Oncology, EarlyView.The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Deep Reinforcement Learning Based Resource Allocation for D2D Communications Underlay Cellular Networks. [PDF]
Sensors (Basel), 2022 Yu S, Lee JW.
europepmc +1 more source
Molecular Oncology, EarlyView.Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
AoI-Aware Optimization of Service Caching-Assisted Offloading and Resource Allocation in Edge Cellular Networks. [PDF]
Sensors (Basel), 2023 Feng J, Gong J.
europepmc +1 more source
Molecular Oncology, EarlyView.Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
A Deep Q-Network-Based Algorithm for Multi-Connectivity Optimization in Heterogeneous Cellular-Networks. [PDF]
Sensors (Basel), 2022 Hernández-Carlón JJ +4 more
europepmc +1 more source
Molecular Oncology, EarlyView.The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
A QoS-Adaptive Interference Alignment Technique for In-Band Full-Duplex Multi-Antenna Cellular Networks. [PDF]
Sensors (Basel), 2022 Lee KH, Park G, Jung BC.
europepmc +1 more source
Molecular Oncology, EarlyView.Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source